Herbalife Nutrition Ltd. (HLF) Key Metrics
HLF valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $1.51B
- Enterprise value
- $3.12B
- P/E (TTM)
- 9.3 10-yr median 13.3
- Forward P/E
- 3.9
- PEG ratio
- 0.61
- Price / sales
- 0.3 10-yr median 0.8
- Price / book
- 31.2
- EV / EBITDA
- 5.9 10-yr median 8.7
- Dividend yield
- —
- Beta
- 0.79
HLF key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsHLF valuation Price multiples at each fiscal year-end price.
HLF returns How much profit the business earns on the capital it uses.
HLF per-share figures Results divided by the shares outstanding at year-end.
HLF financial health Debt, liquidity and how easily interest is covered.
HLF efficiency & capital use Working capital cycle and where the cash goes.
HLF valuation history
HLF returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
HLF debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
HLF cash returned to shareholders
HLF price vs earnings per share
HLF key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $1.34B | $679.7M | $1.53B | $1.48B | $4.43B | $6.46B | $6.75B | $8.81B | $5.61B | $4.14B |
| Enterprise value | $3.32B | $2.73B | $3.72B | $3.89B | $6.84B | $8.09B | $7.92B | $10.07B | $6.60B | $4.75B |
| P/E ratio | 5.8 | 2.7 | 10.8 | 4.6 | 9.9 | 17.3 | 21.7 | 29.7 | 26.2 | 15.9 |
| Price / sales | 0.3 | 0.1 | 0.3 | 0.3 | 0.8 | 1.2 | 1.4 | 1.8 | 1.3 | 0.9 |
| Price / book | — | — | — | — | — | — | — | — | — | 21.1 |
| Price / free cash flow | 5.3 | 4.2 | 6.9 | 7.6 | 14.4 | 12.5 | 19.2 | 15.6 | 11.3 | 18.5 |
| Price / operating cash flow | 4.0 | 2.4 | 4.3 | 4.2 | 9.6 | 10.3 | 14.8 | 13.6 | 9.5 | 11.3 |
| EV / sales | 0.7 | 0.5 | 0.7 | 0.7 | 1.2 | 1.5 | 1.6 | 2.1 | 1.5 | 1.1 |
| EV / EBITDA | 5.4 | 5.4 | 7.7 | 5.7 | 8.3 | 10.8 | 11.7 | 12.8 | 9.2 | 9.0 |
| EV / free cash flow | 13.1 | 16.7 | 16.7 | 19.9 | 22.1 | 15.7 | 22.5 | 17.8 | 13.3 | 21.2 |
| Earnings yield | 17.1% | 37.4% | 9.3% | 21.7% | 10.1% | 5.8% | 4.6% | 3.4% | 3.8% | 6.3% |
| Free cash flow yield | 18.9% | 24.0% | 14.6% | 13.2% | 7.0% | 8.0% | 5.2% | 6.4% | 8.8% | 5.4% |
| Dividend yield | — | — | — | — | — | — | — | — | 0.0% | 0.0% |
| Shareholder yield (dividends + buybacks) | 0.6% | 1.2% | 0.7% | 9.9% | 22.8% | 14.3% | 0.2% | 8.5% | 15.0% | 0.3% |
| Share price at fiscal year-end | $12.89 | $6.69 | $15.26 | $14.88 | $40.93 | $48.05 | $47.67 | $58.95 | $33.86 | $24.07 |
| Per share | ||||||||||
| Revenue per share | $48.62 | $49.14 | $50.52 | $52.31 | $53.58 | $41.20 | $34.44 | $32.72 | $26.72 | $26.07 |
| Earnings per share | $2.20 | $2.50 | $1.42 | $3.23 | $4.13 | $2.77 | $2.20 | $1.98 | $1.29 | $1.51 |
| Operating cash flow per share | $3.22 | $2.81 | $3.57 | $3.54 | $4.25 | $4.67 | $3.23 | $4.34 | $3.57 | $2.13 |
| Free cash flow per share | $2.44 | $1.61 | $2.22 | $1.97 | $2.85 | $3.84 | $2.48 | $3.78 | $2.99 | $1.30 |
| Cash per share | $3.41 | $4.09 | $5.74 | $5.11 | $5.55 | $7.77 | $5.93 | $8.02 | $7.72 | $4.90 |
| Book value per share | −$4.97 | −$7.88 | −$10.58 | −$12.72 | −$12.85 | −$6.37 | −$2.75 | −$4.84 | −$2.02 | $1.14 |
| Tangible book value per share | −$8.98 | −$11.82 | −$14.67 | −$16.83 | −$16.66 | −$9.44 | −$5.59 | −$7.53 | −$4.48 | −$1.18 |
| Dividends per share | — | — | — | — | — | — | — | — | $0.00 | $0.00 |
| Capex per share | $0.78 | $1.20 | $1.35 | $1.57 | $1.40 | $0.83 | $0.75 | $0.56 | $0.58 | $0.83 |
| Debt per share | $22.58 | $24.30 | $27.64 | $29.36 | $27.76 | $19.86 | $14.20 | $16.41 | $13.69 | $8.41 |
| Shares outstanding | 103.6M | 101.6M | 100.2M | 99.5M | 108.3M | 134.5M | 141.6M | 149.5M | 165.7M | 172.2M |
| Change in shares outstanding | +2.0% | +1.4% | +0.7% | −8.1% | −19.5% | −5.0% | −5.3% | −9.8% | −3.8% | +0.9% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | — | — | — | — | — | — | — | — | — | 364.1% |
| Return on invested capital (ROIC) | 26.9% | 32.3% | 21.9% | 38.2% | 65.7% | 59.6% | 59.6% | 73.6% | 42.4% | 44.2% |
| Return on assets (ROA) | 8.3% | 9.2% | 5.1% | 11.6% | 15.2% | 12.9% | 11.4% | 10.4% | 7.8% | 10.3% |
| Return on tangible assets | 9.6% | 10.9% | 5.9% | 13.8% | 18.6% | 14.0% | 13.7% | 12.4% | 8.6% | 12.0% |
| Free cash flow margin | 5.0% | 3.3% | 4.4% | 3.8% | 5.3% | 9.3% | 7.2% | 11.5% | 11.2% | 5.0% |
| Income quality (OCF / net income) | 1.46 | 1.12 | 2.51 | 1.10 | 1.03 | 1.69 | 1.47 | 2.19 | 2.76 | 1.41 |
| Financial health | ||||||||||
| Total debt | $2.34B | $2.47B | $2.77B | $2.92B | $3.01B | $2.67B | $2.01B | $2.45B | $2.27B | $1.45B |
| Cash & short-term investments | $353.1M | $415.3M | $575.2M | $508.0M | $601.5M | $1.05B | $839.4M | $1.20B | $1.28B | $844.0M |
| Net debt | $1.99B | $2.05B | $2.19B | $2.41B | $2.41B | $1.63B | $1.17B | $1.25B | $989.3M | $603.9M |
| Debt / equity | — | — | — | — | — | — | — | — | — | 7.38 |
| Debt / assets | 0.84 | 0.91 | 0.99 | 1.07 | 1.07 | 0.87 | 0.75 | 0.88 | 0.78 | 0.56 |
| Net debt / EBITDA | 3.25 | 4.03 | 4.55 | 3.55 | 2.93 | 2.17 | 1.72 | 1.60 | 1.38 | 1.15 |
| Current ratio | 1.13 | 0.93 | 1.10 | 1.39 | 1.33 | 1.58 | 1.54 | 1.14 | 2.05 | 1.85 |
| Quick ratio | 0.62 | 0.54 | 0.70 | 0.79 | 0.79 | 1.13 | 1.09 | 0.90 | 1.68 | 1.38 |
| Interest coverage | 2.1 | 1.8 | 2.1 | 3.9 | 4.8 | 4.8 | 3.7 | 3.8 | 3.8 | 4.6 |
| Working capital | $131.8M | −$86.7M | $121.7M | $379.5M | $351.4M | $648.5M | $523.8M | $216.2M | $953.5M | $671.0M |
| Invested capital | $1.47B | $1.25B | $1.13B | $1.15B | $1.01B | $769.1M | $780.9M | $531.5M | $654.6M | $800.2M |
| Tangible asset value | −$925.0M | −$1.20B | −$1.47B | −$1.67B | −$1.80B | −$1.27B | −$791.6M | −$1.13B | −$741.7M | −$203.7M |
| Net current asset value | −$2.15B | −$2.39B | −$2.47B | −$2.64B | −$2.78B | −$2.16B | −$1.58B | −$1.71B | −$1.37B | −$906.6M |
| Graham number | — | — | — | — | — | — | — | — | — | $6.22 |
| Graham net-net per share | −$25.26 | −$27.80 | −$29.75 | −$31.62 | −$30.21 | −$19.13 | −$13.78 | −$13.85 | −$10.32 | −$7.47 |
| Capital allocation | ||||||||||
| Dividends paid | — | — | — | — | — | — | — | — | $0 | $0 |
| Share buybacks (net) | $8.2M | $8.3M | $11.0M | $146.7M | $1.01B | $923.5M | $16.7M | $750.3M | $844.2M | $13.2M |
| Dividend payout ratio | — | — | — | — | — | — | — | — | 0.0% | 0.0% |
| Dividends + buybacks / free cash flow | 3.2% | 5.1% | 4.9% | 74.8% | 327.4% | 178.8% | 4.8% | 132.9% | 170.4% | 5.9% |
| Capex / revenue | 1.6% | 2.4% | 2.7% | 3.0% | 2.6% | 2.0% | 2.2% | 1.7% | 2.2% | 3.2% |
| Capex / operating cash flow | 24.1% | 42.7% | 37.8% | 44.4% | 32.9% | 17.8% | 23.2% | 13.0% | 16.2% | 39.0% |
| Capex / depreciation | 0.66 | 1.00 | 1.19 | 1.36 | 1.41 | 1.12 | 1.09 | 0.84 | 0.96 | 1.46 |
| Stock-based compensation / revenue | 0.9% | 1.0% | 0.9% | 0.9% | 0.9% | 0.9% | 0.8% | 0.7% | 1.0% | 0.9% |
| SG&A / revenue | 33.0% | 70.3% | 69.6% | 34.8% | 34.7% | 37.4% | 39.8% | 40.0% | 39.7% | 43.8% |
| Efficiency | ||||||||||
| Days sales outstanding | 5.8 | 5.5 | 5.5 | 4.8 | 4.7 | 5.4 | 5.6 | 6.1 | 6.7 | 5.7 |
| Days of inventory on hand | 146.6 | 162.1 | 166.4 | 179.8 | 158.6 | 148.7 | 155.8 | 143.5 | 153.2 | 150.2 |
| Days payables outstanding | 25.2 | 25.5 | 26.6 | 28.3 | 26.6 | 27.0 | 31.0 | 29.6 | 28.8 | 29.3 |
| Cash conversion cycle (days) | 127.2 | 142.1 | 145.2 | 156.4 | 136.7 | 127.1 | 130.5 | 120.1 | 131.2 | 126.6 |
| Receivables turnover | 62.66 | 66.53 | 66.70 | 75.70 | 77.27 | 68.00 | 64.94 | 59.73 | 54.13 | 64.03 |
| Payables turnover | 14.47 | 14.34 | 13.71 | 12.91 | 13.72 | 13.51 | 11.78 | 12.35 | 12.68 | 12.47 |
| Inventory turnover | 2.49 | 2.25 | 2.19 | 2.03 | 2.30 | 2.45 | 2.34 | 2.54 | 2.38 | 2.43 |
| Asset turnover | 1.83 | 1.80 | 1.83 | 1.87 | 1.97 | 1.93 | 1.78 | 1.72 | 1.62 | 1.78 |
| Average receivables | $80.4M | $75.0M | $75.9M | $68.8M | $75.1M | $81.5M | $75.1M | $81.9M | $81.8M | $70.1M |
| Average payables | $84.9M | $77.0M | $86.9M | $90.9M | $90.3M | $85.2M | $81.3M | $74.5M | $66.9M | $68.5M |
| Average inventory | $493.6M | $490.3M | $543.0M | $578.2M | $538.5M | $468.8M | $409.0M | $361.5M | $356.2M | $351.6M |
| Intangibles / total assets | 14.9% | 14.7% | 14.6% | 15.0% | 14.6% | 13.5% | 15.0% | 14.4% | 14.1% | 15.6% |
Computed from HLF's annual financial statements (latest annual report filed February 18, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
HLF valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Herbalife Nutrition traded at 5.8 times earnings, against a 10-year median of 13.3. Based on the latest twelve months, the trailing P/E is 9.3 and the forward P/E is 3.9. Herbalife Nutrition earned a return on invested capital of 26.9% in fiscal 2025. It ended the year with $2.3 billion of debt and $353.1 million in cash and short-term investments, net debt of $2.0 billion. It returned $8.2 million to shareholders: $0 in dividends and $8.2 million in share buybacks, 3% of free cash flow. The share count fell 39.8% from 172.2M to 103.6M over 9 years.
See the HLF income statement, the HLF chart for price history, or the HLF stock overview for the latest quote and news.
HLF key metrics FAQ
What is Herbalife Nutrition's P/E ratio?
Herbalife Nutrition's trailing P/E ratio is 9.3 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 3.9. At the end of fiscal 2025 it was 5.8, compared with a 10-year median of 13.3.
What is Herbalife Nutrition's EV/EBITDA?
Herbalife Nutrition's enterprise value was 5.4 times EBITDA at the end of fiscal 2025 (enterprise value $3.3 billion, EBITDA $610.7 million); the current EV/EBITDA is 5.9.
What is Herbalife Nutrition's ROIC?
Herbalife Nutrition's return on invested capital was 26.9% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Herbalife Nutrition have?
Herbalife Nutrition had total debt of $2.3 billion at the end of fiscal 2025 and $2.0 billion of net debt (3.25 times EBITDA).
Does Herbalife Nutrition buy back its shares?
Yes. Herbalife Nutrition spent $8.2 million on net share repurchases in fiscal 2025 Shares outstanding changed +2.0% over the year, to 103.6M..
What is Herbalife Nutrition's free cash flow yield?
Herbalife Nutrition generated $252.9 million of free cash flow in fiscal 2025, a free cash flow yield of 18.9% on its market value at year-end ($1.3 billion).
What is Herbalife Nutrition's current ratio?
Herbalife Nutrition's current ratio was 1.13 at the end of fiscal 2025: current assets were 1.13 times current liabilities.